Most Read Articles
18 Jun 2019
The aromatase inhibitor anastrozole shows promise in the treatment of children with congenital adrenal hyperplasia, reducing bone age advancement without adversely affecting bone mineral density and visceral adipose tissue, as shown in a recent study.
22 hours ago
Monotherapy with tenofovir disoproxil fumarate increases virologic response for up to 240 weeks in pretreated patients with hepatitis B virus infection (HBV) who are resistant to entecavir and/or adefovir, a new study has found.
Elvira Manzano, Yesterday
Long-term treatment with the interleukin-5 receptor alpha-directed cytolytic monoclonal antibody benralizumab led to long-term control of asthma, improvement in pulmonary function, and was safe in patients with severe eosinophilic asthma in the 2-year integrated analysis of the SIROCCO, CALIMA, and ZONDA pivotal studies plus the BORA extension study reported at ATS 2019.
Pearl Toh, Yesterday
Emerging evidence is showing that the two major new classes of antidiabetic drugs — SGLT2* inhibitors and GLP-1** receptor agonists (RAs) — not only confer cardiovascular (CV) benefits to patients with type 2 diabetes (T2D), they also delay the loss of kidney function among these patients, potentially providing nephrologists with an additional tool in their armamentarium for managing patients with chronic kidney disease (CKD) in the future.

Psychological distress in pregnancy ups risk of respiratory infections in children

09 Feb 2019

Children whose mothers have experienced psychological distress, such as anxiety and depressive symptoms, during pregnancy are more likely to contract recurrent respiratory infections (RRI) by age 2 years, a recent study has found.

Researchers identified 204 children with (mean maternal age 31.5±4.4 years) and 1,014 without (mean maternal age 31.1±4.3 years) RRIs. Maternal psychological distress and parental relationship quality at 34 weeks of gestation were measured using The Edinburgh Postnatal Depression Scale (EPDS), Symptom Checklist-90 anxiety subscale (SCL90/Anxiety), the Pregnancy-Related Anxiety Questionnaire–Revised 2 (PRAQ-R2) and the Revised Dyadic Adjustment Scale (RDAS).

Mothers in the RRI group reported significantly higher scores on all scales, suggesting that symptoms of depression (p<0.001), anxiety (p=0.04) and pregnancy-specific anxiety (p=0.001) were all elevated, while parental relationship satisfaction was reduced (p=0.008).

Postnatal distress levels were similar. Compared with mothers in the comparison group, those in the RRI group reported significantly greater depressive (p=0.001) and anxiety (p=0.03) symptoms, while relationship satisfaction with the child at 2 years of age remained lower (p=0.003).

Logistic regression analysis further confirmed that scores in the EPDS (odd ratio [OR], 1.24; 95 percent CI, 1.08–1.44; p=0.003) and RDAS (OR, 1.32; 1.01–1.58; p=0.003) at 34 weeks of gestation were significantly and positively correlated with offspring RRIs at age 2 years.

The same was true for the SCL90/Anxiety (OR, 1.40; 1.01–1.76; p=0.006) and the PRAQ-R2 (OR, 1.28; 1.11–1.47; p=0.001). The above relationships remained significant even after controlling for the number of siblings and the duration of breastfeeding.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
18 Jun 2019
The aromatase inhibitor anastrozole shows promise in the treatment of children with congenital adrenal hyperplasia, reducing bone age advancement without adversely affecting bone mineral density and visceral adipose tissue, as shown in a recent study.
22 hours ago
Monotherapy with tenofovir disoproxil fumarate increases virologic response for up to 240 weeks in pretreated patients with hepatitis B virus infection (HBV) who are resistant to entecavir and/or adefovir, a new study has found.
Elvira Manzano, Yesterday
Long-term treatment with the interleukin-5 receptor alpha-directed cytolytic monoclonal antibody benralizumab led to long-term control of asthma, improvement in pulmonary function, and was safe in patients with severe eosinophilic asthma in the 2-year integrated analysis of the SIROCCO, CALIMA, and ZONDA pivotal studies plus the BORA extension study reported at ATS 2019.
Pearl Toh, Yesterday
Emerging evidence is showing that the two major new classes of antidiabetic drugs — SGLT2* inhibitors and GLP-1** receptor agonists (RAs) — not only confer cardiovascular (CV) benefits to patients with type 2 diabetes (T2D), they also delay the loss of kidney function among these patients, potentially providing nephrologists with an additional tool in their armamentarium for managing patients with chronic kidney disease (CKD) in the future.